(Q45068304)

9 December 2017

title

A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbits (English)

1 reference

9 December 2017

1 reference

11

Louis J Ignarro

1 reference

9 December 2017

Toshio Hayashi

1

1 reference

9 December 2017

Juliet Arockia Rani P

2

1 reference

9 December 2017

Akiko Fukatsu

3

1 reference

9 December 2017

Hisako Matsui-Hirai

4

1 reference

9 December 2017

Masako Osawa

5

1 reference

9 December 2017

Asaka Miyazaki

6

1 reference

9 December 2017

Taku Tsunekawa

7

1 reference

9 December 2017

Hatsuyo Kano-Hayashi

8

1 reference

9 December 2017

Akihisa Iguchi

9

1 reference

9 December 2017

Daigo Sumi

10

1 reference

9 December 2017

publication date

1 October 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

176

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

255-263

1 reference

HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide

9 December 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Physiological concentration of 17beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

The reaction of no with superoxide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Superoxide and peroxynitrite in atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Biochemical functions of coenzyme Q10

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-))

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Regulation of the mevalonate pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigenin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Neuroprotective properties of statins in cerebral ischemia and stroke

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ATHEROSCLEROSIS.2003.12.034

Identifiers

DOI

10.1016/J.ATHEROSCLEROSIS.2003.12.034

1 reference

9 December 2017

1 reference